Related Experiment Video
Updated: Feb 16, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer
Tao Yu1,2, Hai-Ru Yu2, Jia-Yi Sun2
1Department of Breast Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang 110042, P.R.China.
Abstract:
Attenuation of estrogen receptor α (ERα) expression via unknown mechanism(s) is a hallmark of endocrine-resistant breast cancer (BCa) progression. Here, we report that miR-1271 was significantly down-regulated in letrozole-resistant BCa tissues and in letrozole-resistant BCa cells. miR-1271 directly targeted the chromatin of DNA damage-inducible transcript 3 (DDIT3) gene. miR-1271 expression level was inversely correlated to DDIT3 mRNA level in BCa biopsies. Form a mechanistic standpoint, reintroduction of exogenous miR-1271 could effectively restore ERα level via inhibiting DDIT3 expression, thereby potentiating letrozole sensitivity in BCa cells. Moreover, DDIT3 deregulation promoted letrozole-resistance by acting as a potent corepressor of ESR1 transcription. Taken together, we have identified that disruption of the miR-1271/DDIT3/ERα cascade plays a causative role in the pathogenesis of letrozole resistance in BCa.
Insights
MicroRNA-1271 (miR-1271) downregulation contributes to letrozole resistance in breast cancer by increasing DNA damage-inducible transcript 3 (DDIT3) and reducing estrogen receptor α (ERα). Restoring miR-1271 can re-sensitize breast cancer to letrozole.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Endocrine-resistant breast cancer (BCa) is characterized by reduced estrogen receptor α (ERα) expression through poorly understood mechanisms.
- Letrozole resistance is a significant clinical challenge in BCa treatment, necessitating a deeper understanding of its molecular underpinnings.
Purpose of the Study:
- To elucidate the role of microRNA-1271 (miR-1271) in the development of letrozole resistance in breast cancer.
- To investigate the molecular mechanisms by which miR-1271 influences ERα expression and drug sensitivity.
Main Methods:
- Quantification of miR-1271 and DDIT3 mRNA levels in letrozole-resistant and sensitive BCa tissues and cells.
- Chromatin immunoprecipitation assays to determine direct targeting of the DDIT3 gene by miR-1271.
- Functional studies involving reintroduction of miR-1271 into resistant cells to assess its impact on ERα levels and drug sensitivity.
- Analysis of DDIT3's role as a corepressor of ESR1 transcription.
Main Results:
- miR-1271 was significantly downregulated in letrozole-resistant BCa tissues and cells.
- miR-1271 directly targets the DDIT3 gene, with its expression inversely correlated to DDIT3 mRNA levels.
- Restoring miR-1271 inhibited DDIT3, increased ERα levels, and restored sensitivity to letrozole in BCa cells.
- DDIT3 deregulation promoted letrozole resistance by repressing ESR1 transcription.
Conclusions:
- The miR-1271/DDIT3/ERα signaling axis is critically disrupted in letrozole-resistant breast cancer.
- Downregulation of miR-1271 is a key driver of letrozole resistance, mediated by DDIT3-induced repression of ERα.
- Targeting the miR-1271/DDIT3 pathway offers a potential therapeutic strategy to overcome endocrine resistance in BCa.
Related Concept Videos
Treatment Resistant Cancers
Feedback Inhibition
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Resistivity
Resistance
Enzyme Inhibition

